Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C —can one size fit all?

This article is linked to El‐Khayat et al paper. To view this article visit https://doi.org/10.1111/apt.14482.

Source: Alimentary Pharmacology and Therapeutics - February 15, 2018 Category: Drugs & Pharmacology Authors: J. Sun, X. Liang, R. Fan, J. Hou Tags: INVITED EDITORIALS Source Type: research